XML 34 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisition - Allocation of Consideration Transferred for Crescendo (Detail) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Jun. 30, 2014
Feb. 28, 2014
Business Acquisition [Line Items]      
Goodwill $ 185,228us-gaap_Goodwill $ 169,181us-gaap_Goodwill  
Crescendo Biosciences, Inc.      
Business Acquisition [Line Items]      
Other assets acquired     15,826us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember
Intangible assets     196,600us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember
Goodwill     112,331us-gaap_Goodwill
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember
Total assets acquired     324,757us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember
Deferred tax liability     44,213us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember
Other liabilities assumed     21,594us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember
Total net assets acquired     $ 258,950us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= mygn_CrescendoBioscienceIncMember